Drawing for APTAMIR

USPTO serial 85624392

APTAMIR

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
STEEL, ALYSSA PALADINO
Law office
TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with APTAMIR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark D. Godler

MARK D. GODLER Kaye Scholer LLP250 West 55th StreetNew York, NY 10019-9710UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medicinal and biological preparations for research, laboratory use, pharmaceutical, clinical or medical laboratory use, namely, preparations for the modulation of gene and protein expression working at DNA transcription, RNA translation and/or degradation processes related theretoACTIVE—
042MicroRNA-targeted pharmaceutical drug research and development in the field of biotech herapeutics; development of RNA-based pharmaceutical drugs and therapeutic compounds; development of drugs for the pharmaceutical and biotech industries for the treatment of a wide variety of diseases and other conditions, namely, cardiovascular diseases, endocrine and metabolic diseases, obesity and weight disorders, hepatic and gastro-intestinal diseases, inflammatory diseases, and malignant diseases; Scientific and technological research services, namely, profiling and analysis of miRNA sequences; developing computer generated models and simulations for others; providing "in vitro" and "in vivo" preclinical and clinical testing of microRNA analogs and aptamers for scientific, research, healthcare, product development, consulting, and educational purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 7, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 9, 2013MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 9, 2013ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 4, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 28, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 28, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 5, 2012GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 5, 2012GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 5, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 5, 2012DOCKASSIGNED TO EXAMINER—
May 22, 2012MPMKNOTICE OF PSEUDO MARK MAILED—
May 18, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 17, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance